Design Therapeutics, Inc.DSGNNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank50
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
-26.11%
↑ 97% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-923.44%
Historical baseline
PeriodValue
2025-26.11%
202426.39%
2023-14.11%
2022-74.68%
2021-238.87%
2020-6136.69%
20190.00%